Skip to main content
Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — Thursday, April 4, 2024

Thursday, April 4, 2024 at 8:00 a.m.
Posted: March 11, 2024 1:15 p.m.

Overview   of Board of Registration in Pharmacy (via Webex) — Thursday, April 4, 2024

A meeting of the Board of Registration in Pharmacy: This meeting is open to the public by Webex or telephone.

Join by Webex

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Access code: 2537 378 1431

Agenda

Time      

#

Item

8:00

I

CALL TO ORDER

8:02

II

APPROVAL OF AGENDA

8:05

III

APPROVAL OF BOARD MINUTES

  • Draft of March 7, 2024, Regular Session Minutes

8:10

IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation  
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • PSUD Report-Policy 17-03
  • Research Drug Study report pursuant to Staff Action Policy 18-02

8:15

V

FLEX

  • Board Policy 2022-01: Loss or Theft of Controlled Substance
    • Reporting will be via ELX platform
  • Letter on Implantable Infusion Pumps

8:20

VI

REGULATION

  • 247 CMR 2.00: Definitions and Severability

8:30

VII

APPLICATIONS

  •  Meraki Pharmacy- New Community Pharmacy

9:00

VIII

FILE REVIEW

1

CASE-2023-0742

PHA-2023-0259

Rite Aid #10209, DS2899

2

CAS-2023-0113

PHA-2023-0221

Shifa Ali, PH239619 

3

CASE-2023-0658

PHA-2023-0239

Optum Infusion Services, DS90100

4

CASE-2023-0740

PHA-2023-0262

Soleo Health, DS89958

5

CASE-2023-0740

PHA-2023-0263

Kimmi Cheung, PH238352

6

CASE-2024-0128

PHA-2024-0023

Walgreens #2564, DS1925

7

CASE-2023-0826

PHA-2023-0274

West Concord Pharmacy, DS3607

8

CASE-2023-0783

PHA-2023-0269

Stop & Shop #784, DS2132

9

CASE-2023-0508

PHA-2023-0231

Blue Hill Pharmacy, DS89942 

10

CASE-2023-0508

PHA-2024-0026

Victoria Okeke, PH25059

11

CASE-2023-0763

PHA-2023-0266

Walgreens #10209, DS3529

12

CASE-2023-0738

PHA-2023-0260

CVS #505, DS89977

13

CAS-2023-1132

PHA-2024-0016

Laura DeSimone, PT5232

14

CASE-2023-0540

PHA-2024-0010

Gregory Rodrigues, PH23347

15

CASE-2023-0620

PHA-2023-0219

CVS #2339, DS2877

16

CASE-2023-0594

PHA-2023-0256

CVS #166, DS3449

17

CASE-2023-0677

PHA-2023-0251

CVS #1007, DS90074

18

CAS-2023-0898

PHA-2023-0271

Gabriel Rusanescu, PH239940

19

CASE-2023-0675

PHA-2023-0250

CVS #635, DS2871

20

CAS-2021-0591

PHA-2023-0272

Xia Li, PH233540

21

CASE-2023-0618

PHA-2023-0217

CVS #719, DS1906

22

CASE-2023-0616

INV8553

CVS #119, DS89835

23

CASE-2023-0686

PHA-2023-0246

Coram CVS/ Specialty Infusion Services, DS3601

10:30

IX

RECONSIDERATION

  • Compare Quality Pharmacy, DS89874, PHA-2019-0043

11:00

X

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, evaluate the Good Moral Character as required for registration for a pending applicant. The

11:30

 

LUNCH BREAK

12:00

XI

M.G.L. c. 112, § 65C SESSION

4:00

XII

ADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback